Cite
HARVARD Citation
Matsubara, N. et al. (n.d.). 797PDLATITUDE study: PSA response characteristics and correlation with overall survival (OS) and radiological progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving ADT+abiraterone acetate and prednisone (AAP) or placebo (PBO). Annals of oncology. p. . [Online].